In vivo anticancer activity of vanillin semicarbazone.

Abstract

OBJECTIVE To evaluate the anticancer activity of vanillin semicarbazone (VSC) against Ehrlich ascites carcinoma (EAC) cells in Swiss albino mice. METHODS The compound VSC at three doses (5, 7.5 and 10 mg/kg i.p.) was administered into the intraperitoneal cavity of the EAC inoculated mice to observe its efficiency by studying the cell growth inhibition… (More)
DOI: 10.1016/S2221-1691(12)60072-0

Topics

11 Figures and Tables

Slides referencing similar topics